The COVID-19 pandemic paused many HIV prevention efforts, which helped fuel last year's rise in new infections. President ...

Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?

It is already approved in multiple countries for the treatment of multi-drug-resistant HIV and is now entering the prevention space with unprecedented speed. That speed is critical.

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

A recent study analyzes the extent to which HIV tests are conducted following the diagnosis of an HIV indicator condition (IC ...

Methodist College has partnered with the National Library of Medicine to bring a traveling exhibit to the college, raising ...

UNAIDS statistics indicate that adolescent girls and young women (AGYW) aged 15-24 years continue to face a significant risk of HIV acquisition.

Thirty-five years ago, the multimillion dollar fundraiser Seventh on Sale propelled the fashion industry into a new era of ...

There are many diseases that mosquitoes can transmit, but HIV isn't one of them. Here's why, and what viruses you do need to watch out for depending on where you live.

Gilead has partnered with six generic manufacturers to expand access to HIV Drug lenacapavir in high-incidence, resource-limited countries following promising clinical trial results.

Gilead Sciences has achieved success with its HIV treatment drugs, including tenofovir disoproxil fumarate, but faces criticism for pricing and access issues. Learn about the controversy and ...

Writing in the latest edition of the journal, the editors argue that the Trump administration’s recent dismantling of public ...